A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma
Coherence Neuro Australia Pty Limited
10 participants
May 1, 2026
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to collect data on the use of the CIPHER System when used by a surgeon during brain tumor removal. The main questions it aims to answer are: * To evaluate the safety of the CIPHER System when used during brain tumor surgery (Primary) * To evaluate the function of the electrodes under recording and stimulating conditions during surgery (Secondary) Participants will undergo standard-of-care surgery to remove their tumor. Just before the tumor is removed, the CIPHER System will be tested on the main tumor and the surrounding margin areas. Participants will be monitored during standard hospital visits occurring during the recovery period after surgery as well as two- and six-weeks after surgery.
Eligibility
Inclusion Criteria6
- Newly diagnosed supratentorial glioma requiring resection
- Glioma mass reaches or close to cortical surface
- Adults aged 18-75
- Planned for open craniotomy under Total Intravenous Anesthesia (TIVA)
- Patient able to provide informed consent
- Performance status: Eastern Cooperative Oncology Group (ECOG) scale 0-2
Exclusion Criteria5
- Prior craniotomy at the same anatomical location
- Plan for awake craniotomy
- Any history of seizures prior to craniotomy
- Any history of coagulopathy or coagulation disorders
- Pregnant status during craniotomy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Electrocorticography probe placed on the brain surface for neural recording
Electrocorticography probe placed on the brain surface for neural recording and electrical stimulation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07465796